Regular follow-up appointments, typically scheduled every 4 to 12 weeks during the initial treatment phase, allow for dose adjustments, side effect management, and monitoring of therapeutic outcomes
Lyon: IARC
NLY01 exerts its neuroprotective effect by potently suppressing this pathogenic inflammatory axis, thereby attenuating the formation of cytotoxic A1 astrocytes and preserving RGC viability [42]
When the body lacks enough fluids, the kidneys concentrate urine to save water
doi:10.1056/NEJMoa2301972 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z